Leica Biosystems Launches ChromoPlex III Detection System to Streamline Chromogenic Multiplex IHC for Reproducible, Digital-Ready Staining

Plug-and-play simplicity meets the demands of modern digital pathology workflows.

Written byLeica Biosystems
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Leica Biosystems, a global leader in anatomic and digital pathology solutions, today unveiled ChromoPlex III Triple Detection RUO, a chromogenic multiplex immunohistochemistry detection system engineered to simplify assay setup and reduce variability. ChromoPlex III is built to fit seamlessly into Leica Biosystems’ end-to-end translational research ecosystem—stain on BOND RX, scan with Aperio, and analyze with HALO.

The launch comes as researchers seek more accessible and clinically relevant multiplex IHC tools to advance spatial biology and better characterize the tumor microenvironment. ChromoPlex III meets these needs by delivering consistent, reproducible chromogenic staining optimized for high-resolution digital imaging and computational pathology workflows.

ChromoPlex III Triple Detection RUO

ChromoPlex III’s plug-and-play format reduces manual steps and eliminates the need for antibody conjugation. Researchers simply select their antibodies, assign chromogen colors (brown, red, or green), load the kit onto the BOND RX or RXm stainer, and initiate their assay. With pre-optimized reagents and protocols, ChromoPlex III helps streamline detection workflows and minimizes setup variability.

“ChromoPlex III is built to meet the evolving needs of researchers working at the intersection of spatial biology and computational pathology,” said Karan Arora, Senior Vice President of Advanced Assays, Pharma Services, and AI at Leica Biosystems. “Its chromogenic format mirrors clinical diagnostics, allowing researchers and pathologists to visualize tissue architecture while producing reproducible results that are essential for image analysis and AI interpretation.”

“The launch of ChromoPlex III underscores Leica Biosystems’ commitment to accelerating cancer research and advancing the future of diagnostics and therapies,” shared Gustavo Perez, President at Leica Biosystems. “By combining ease of use with digital compatibility, ChromoPlex III helps researchers generate high-resolution, quantifiable data to support the development of more precise and personalized treatment strategies.”

ChromoPlex III is available now for research use only. Visit our ChromoPlex III Image Gallery to explore interactive whole slide images and see how the plug-and-play kit delivers high-quality, consistent staining essential for AI image analysis.

For Research Use Only. Not For Use In Diagnostic Procedures.

Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas